During the past decade, Oncologico Potosino conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 2 clinical trials were completed, i.e. on average, 9.5% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 2 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oncologico Potosino" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Arcus Biosciences, Inc." with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oncologico Potosino" #1 collaborator was "Abogen Biosciences Co. Ltd." with 1 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Genmab" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Oncologico Potosino" are "Early Breast Cancer" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Non-Small Cell Lung Cancer" (2 trials), "Triple Negative Breast Cancer" (2 trials) and "Adenocarcinoma" (1 trials). Many other conditions were trialed in "Oncologico Potosino" in a lesser frequency.

Most popular intervention types in "Oncologico Potosino" are "Drug" (20 trials), "Radiation" (3 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (6 trials), "Paclitaxel" (6 trials), "Carboplatin" (5 trials), "Atezolizumab" (4 trials) and "Cisplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Oncologico Potosino" are 20 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Oncologico Potosino". undefined are not yet recruiting, 13 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Oncologico Potosino, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oncologico Potosino, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".